Angelika Holler

Author PubWeight™ 13.19^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination.	Blood	2011	1.55
2	CD3 limits the efficacy of TCR gene therapy in vivo.	Blood	2011	1.55
3	Monoclonal T-cell receptors: new reagents for cancer therapy.	Mol Ther	2007	1.34
4	Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.	Proc Natl Acad Sci U S A	2009	1.34
5	Detection of Wilms' tumor antigen--specific CTL in tumor-draining lymph nodes of patients with early breast cancer.	Clin Cancer Res	2006	0.97
6	Human MHC Class I-restricted high avidity CD4(+) T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.	Oncoimmunology	2013	0.88
7	CD8alpha/alpha homodimers fail to function as co-receptor for a CD8-dependent TCR.	Eur J Immunol	2007	0.88
8	Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes.	Cancer Res	2004	0.85
9	WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.	Blood Cells Mol Dis	2007	0.85
10	Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.	Expert Opin Biol Ther	2005	0.78
11	A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function.	PLoS One	2007	0.76
12	Generation and characterization of transgenic mice expressing a T-cell receptor specific for the tumour-associated antigen MDM2.	Immunology	2008	0.76
13	Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design.	Mol Med	2007	0.75